Trevi Therapeutics TRVI
NASDAQ TRVI
$13.91 -0.27 (-1.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Change in Accured Expenses (2018 - 2026)

Updated

Trevi Therapeutics (TRVI) posted Change in Accured Expenses of $685,000 for Q2 2026, up 37.6% from $498,000 a year earlier.

Analysis

Trevi Therapeutics (TRVI) Change in Accured Expenses (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Trevi Therapeutics was -$802,000; for FY2025, it was -$1.42 million.

  • In prior years, Trevi Therapeutics' Change in Accured Expenses was $2.56 million in FY2024, $52,000 in FY2023, -$639,000 in FY2022 and $336,000 in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Change in Accured Expenses since Q3 2024.
  • On a year-over-year basis, Change in Accured Expenses increased in two of the last four quarters, with growth averaging 9.0%.
  • The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q3 2022, with growth of 241.1%; the weakest was Q1 2022, with a decline of 96.9%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$1.08 million (Q1 2026), -$555,000 (Q4 2025) and $143,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Trevi Therapeutics 1.98 Bn 1.98 Bn - 685,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 685,000.00
Mar 31, 2026 -1.08 Mn
Dec 31, 2025 -555,000.00
Sep 30, 2025 143,000.00
Jun 30, 2025 498,000.00
Mar 31, 2025 -1.50 Mn
Dec 31, 2024 -713,000.00
Sep 30, 2024 2.20 Mn
Jun 30, 2024 2.02 Mn
Mar 31, 2024 -940,000.00
Dec 31, 2023 24,000.00
Sep 30, 2023 823,000.00
Jun 30, 2023 -732,000.00
Mar 31, 2023 -63,000.00
Dec 31, 2022 -1.30 Mn
Sep 30, 2022 307,000.00
Jun 30, 2022 336,000.00
Mar 31, 2022 14,000.00
Dec 31, 2021 556,000.00
Sep 30, 2021 90,000.00
API Access

Trevi Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TRVI&period=max&api_key=YOUR_API_KEY